This is the authors' abstract. We don't add key points for this paper.
To the Editor: Hearing loss (HL) is a common but underappreciated health problem affecting older adults. The functional consequences of HL for older adults are now surfacing in epidemiological studies demonstrating that HL may be independently associated with depression1 and loneliness.2 HL is more strongly associated with the development of depression in older adults than other medical comorbidities.1 Whether hearing rehabilitative treatment may mitigate the possible effects of HL on depression remains unclear. The association between HL and hearing aid use and major depressive disorder (MDD) was investigated in a nationally representative study of older patients. Data from the 2005–06 and 2009–10 2-year cycles of the National Health and Nutrition Examination Survey (NHANES), an epidemiological study designed to assess the health, functional, and nutritional status of the civilian, noninstitutionalized U.S. population, were analyzed. During these survey cycles, audiometry was performed in adults aged 70 and older. Participants were also administered the Patient Health Questionnaire (PHQ-9),3 a self-reported depression assessment instrument based on Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, symptoms and signs of MDD. The analytical cohort consisted of 1,029 adults aged 70 to 79 who completed audiometric testing as well as the PHQ-9. Hearing was defined according to the speech-frequency pure-tone average of hearing thresholds at 0.5, 1, 2, and 4 kHz in the better-hearing ear. Participants were classified as having MDD or any depressive symptoms if either of the initial questions addressing depressed mood was answered as “more than half the days” or “nearly every day” and the PHQ-9 score was 10 and greater or 5 and greater, respectively. Scores of 10 and greater have 88% sensitivity and specificity for MDD, and scores of 5 or greater represent mild depression.4 Data were analyzed using stepwise multivariate logistic models to investigate the association between HL as a continuous variable (per 25 dB) and hearing aid use and MDD and any depressive symptoms, adjusting for demographic characteristics and cardiovascular risk factors. Hearing aid use was defined as wearing a hearing aid at least 5 hours per week in the 12 months before the interview. All significance tests were two-sided with a type I error rate of 0.05. All analyses were performed using SAS version 9.3 (SAS Institute, Inc., Cary, NC). At baseline, 602 (58.5%) participants had 25-dB or more HL, 38 (3.9%) met criteria for MDD, and 71 (7.4%) met criteria for having any depressive symptoms. Greater HL (per 25 dB) was not significantly associated with greater odds of MDD (odds ratio (OR) = 1.63, 95% confidence interval (CI) = 0.66–4.98), or any depressive symptoms (Table 1) (OR = 1.58, 95% C = 0.77–3.25). Hearing aid use was associated with lower odds of MDD (OR = 0.35, 95% C = 0.14–0.90) and any depressive symptoms (OR = 0.33, 95% C = 0.14–0.77) in the fully adjusted model (Table 2). These results demonstrate that hearing aid use is significantly associated with lower odds of MDD and any depressive symptoms, consistent with prior studies.5-8 Two small, single-arm prospective studies showed reductions in depressive symptoms within 3 months of hearing aid use.7, 8 Similar results have been demonstrated in the Blue Mountains Study, in which hearing aid use was associated with lower odds (OR = 0.32) of having depressive symptoms.5 Prospective longitudinal studies in nursing home participants have shown similar reductions in depressive symptoms (OR = 0.30)6 and improvement in mental health in ambulatory individuals with hearing aid use.8 The strength of the current study is the use of the PHQ-9 to evaluate for depressive symptomatology and MDD. Furthermore, these results are based on a generalizable cohort of older adults. The direction of the observed association between hearing aid use and depression cannot be determined in the present study. For example, individuals without depression may be more likely to obtain hearing aids than individuals who are depressed. Alternatively, individuals who are more health conscious and less likely to have depressive symptoms may also be more likely to use hearing aids, although it is equally possible that HL treatment could help promote social engagement and thereby reduce depressive symptoms.8 In the present analysis, HL was not associated with greater odds of having MDD or any depressive symptoms in contrast to other cross-sectional and prospective longitudinal studies evaluating depressive symptomatology.1, 5, 9, 10 One possible explanation for this is the small number of participants who met the strict criteria for MDD based on the PHQ-9 guidelines. In summary, hearing aid use is independently associated with lower odds of MDD and depressive symptoms. The basis of this association and whether hearing rehabilitative interventions could reduce depressive symptoms will require further study in other prospective studies or a randomized clinical trial. Conflict of Interest: Dr. Lin was supported by a grant from the National Institutes of Health (1K23DC011279), a Triological Society/American College of Surgeons Clinician Scientist Award, and the Eleanor Schwartz Charitable Foundation. Dr. Lin has served as a consultant to Cochlear Corp and Autifony, serves on the scientific advisory board for Autifony, and is speaker for Amplifon and Cochlear Corp.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Mener et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: